The possibility of 'de novo' cancer in the prostate

Int J Urol. 2005 Apr;12(4):361-4. doi: 10.1111/j.1442-2042.2005.01023.x.

Abstract

Background: To investigate the possibility of 'de novo' prostate cancer by analyzing the relationship between high grade prostatic intraepithelial neoplasia (HGPIN) and latent prostate cancer.

Materials and methods: Latent prostate cancers found at autopsy were examined and 55 cancer foci with a poorly (Gleason grade 4 and 5) or moderately (Gleason grade 3) differentiated component were selected. The 55 foci were separated into two groups: (i) foci with either a poorly or moderately differentiated component only (single differentiation group, SDG); and (ii) mixed foci with two or more types of differentiation components (mixed differentiation group, MDG). High grade intraepithelial neoplasia was defined as positive if it was observed within 2 mm from the edge of the cancer focus and the relationship between HGPIN and the two groups was investigated.

Results: The MDG had 39 cancer foci (71.0%) and there were 16 in the SDG (29.0%). There were 31 foci that were small-volume cancers (<0.2 mL). In the MDG, 13 small-volume cancer foci were HGPIN positive, but in the SDG, none of the small-volume cancers were HGPIN positive.

Conclusions: Small-volume cancer foci without HGPIN in the SDG may be candidates for de novo prostate cancers.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma / pathology*
  • Aged
  • Aged, 80 and over
  • Autopsy
  • Diagnosis, Differential
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Prostatic Intraepithelial Neoplasia / pathology*
  • Prostatic Neoplasms / pathology*
  • Retrospective Studies
  • Severity of Illness Index